Macropinocytosis and cytoskeleton contribute to dendritic cell-mediated HIV-1 transmission to CD4+ T cells  by Wang, Jian-Hua et al.
Virology 381 (2008) 143–154
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roMacropinocytosis and cytoskeleton contribute to dendritic cell-mediated HIV-1
transmission to CD4+ T cells
Jian-Hua Wang a, Clive Wells b, Li Wu a,⁎
a Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
b Electron Microscopy Core Facility, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA⁎ Corresponding author. Fax: +1 414 456 6535.
E-mail address: liwu@mcw.edu (L. Wu).
0042-6822/$ – see front matter. Published by Elsevier I
doi:10.1016/j.virol.2008.08.028a b s t r a c ta r t i c l e i n f oArticle history: Dendritic cells (DCs) are a
Received 11 July 2008
Returned to author for revision 12August 2008
Accepted 15 August 2008
Available online 18 September 2008
Keywords:
HIV-1
Dendritic cells
Transmission
Cytoskeleton
Macropinocytosis
CD4+ T cellsmong the ﬁrst immune cells to encounter HIV-1 at the initial infection. DCs
efﬁciently transfer HIV-1 to CD4+ T cells via infectious or virological synapses formed between DCs and T
cells. Retroviruses exploit the cytoskeletal network to facilitate viral infection and dissemination; however,
the role of the cytoskeleton in DC-mediated HIV-1 transmission is unknown. Here, we report that intact
cytoskeleton is essential for DC-mediated HIV-1 transmission to CD4+ T cells. We found that
macropinocytosis of HIV-1 contributes to DC-mediated HIV-1 endocytosis and transmission. Blocking HIV-
1 macropinocytosis and disrupting actin or microtubules in DCs with speciﬁc inhibitors signiﬁcantly
prevented DC-mediated HIV-1 trans-infection of CD4+ T cells. Altered HIV-1 trafﬁcking and impaired
formation of virological synapses primarily accounted for the inhibition of viral transmission by cytoskeletal
inhibitors. Our results provide new insights into the mechanisms underlying DC-mediated HIV-1
transmission to CD4+ T cells via the cytoskeletal network.
Published by Elsevier Inc.Introduction
Dendritic cells (DCs) are among the ﬁrst immune cells to encounter
HIV-1 (referred to subsequently as HIV) at the initial infection, they play
an important role in viral pathogenesis (Cameron et al., 1992, 2007;
Hladik et al., 2007; Pope et al., 1994). Deﬁning the mechanisms of DC-
mediated HIV transmission can enhance our understanding of viral
pathogenesis (Piguet and Steinman, 2007; Wu and KewalRamani,
2006). DCs efﬁciently transfer HIV to CD4+ T cells via infectious or
virological synapses (VS) (Arrighi et al., 2004; Ganesh et al., 2004;
Garcia et al., 2005, 2008; Hladik et al., 2007; McDonald et al., 2003;
Turville et al., 2004; Wang et al., 2007b), which are the synaptic
junctions of DC-T-cells with concentrated HIV and viral receptors
(McDonald et al., 2003). Immature DCs (iDCs) in submucosal tissues can
capture HIV and migrate to lymphoid tissues, where they become
mature DCs (mDCs) and effectively spread viral infection to CD4+ T cells
(reviewed in Wu, 2008; Wu and KewalRamani, 2006). Notably, mDCs
signiﬁcantly facilitate HIV endocytosis and efﬁciently concentrate HIV at
VS (Garcia et al., 2005; Izquierdo-Useros et al., 2007; Turville et al.,
2004; Wang et al., 2007b), which contributes to mDC-enhanced viral
transmission, at least in part. However, the mechanisms underlying DC-
mediated HIV transmission remain to be elucidated.
Retroviruses exploit the cytoskeletal network to facilitate viral
infection and dissemination (Fackler and Krausslich, 2006; Naghavinc.and Goff, 2007). Understanding the role of cytoskeleton in cell–cell
transmission of HIV can potentially aid in the development of
interventions against HIV infection. Efﬁcient HIV spread between
CD4+ T cells occurs via actin-dependent VS (Chen et al., 2007; Jolly
et al., 2004, 2007). Recent studies suggest that actin-dependent
ﬁlopodial bridges and intercellular membrane nanotubes mediate
cell-to-cell transmission of retroviruses (Sherer et al., 2007;
Sowinski et al., 2008). However, the role of the cytoskeleton in
DC-mediated HIV transmission is unclear.
HIV trafﬁcking in DCs contributes to viral transmission to CD4+ T
cells (Fahrbach et al., 2007; Garcia et al., 2005; Izquierdo-Useros et al.,
2007; McDonald et al., 2003; Trumpfheller et al., 2003; Turville et al.,
2004; Wang et al., 2007b; Wiley and Gummuluru, 2006). DCs
endocytose HIV or simian immunodeﬁciency virus (SIV) through
various pathways, including clathrin-mediated endocytosis (Frank
et al., 2002; Garcia et al., 2005;Wang et al., 2007b), receptor-mediated
endocytosis (de Witte et al., 2007; Kwon et al., 2002), and likely
macropinocytosis (Frank et al., 2002; Turville et al., 2004; Wang et al.,
2007b). Macropinocytosis is an actin-dependent process bywhich DCs
constitutively engulf large volumes of ﬂuid and whole pathogens
(Falcone et al., 2006; Marsh and Helenius, 2006; Sallusto et al., 1995;
Wu and KewalRamani, 2006). Interestingly, mDCs are more efﬁcient
than iDCs in endocytosing HIV or SIV (Frank et al., 2002; Turville et al.,
2004; Wang et al., 2007b). The large intracellular compartments that
conﬁne numerous HIV or SIV particles in mDCs (Frank et al., 2002;
Turville et al., 2004; Wang et al., 2007b) appeared similar to
macropinocytosis-mediated HIV entry into macrophages and brain
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However, the role of macropinocytosis in DC-mediated HIV transmis-
sion is currently unknown.
In this study, we report that intact cytoskeleton is essential for DC-
mediated HIV transmission to CD4+ T cells. Blocking actin-dependent
macropinocytosis of HIV and disrupting actin or microtubules in DCs
with speciﬁc inhibitors signiﬁcantly inhibited DC-mediated HIV
transmission. The inhibition of HIV transmission was mainly due to
altered viral trafﬁcking and impaired VS formation. These ﬁndings
provide new insights into the mechanisms underlying DC-mediated
HIV transmission to T cells, suggesting that reversible disruption of
cytoskeleton by speciﬁc inhibitors could be considered as a potential
therapeutic approach against HIV infection.
Results
F-actin and macropinocytosis contribute to DC endocytosis of HIV
HIV enters DCs primarily through endocytosis rather than the viral
receptor-mediated fusion pathway (Cavrois et al., 2006; Dong et al.,
2007; Janas et al., 2008). Tomeasure HIV endocytosed in DCs, iDCs and
lipopolysaccharide (LPS)-induced mDCs were pulsed with single-
cycle, luciferase reporter HIV (HIV-Luc/JRFL) in the presence of speciﬁc
inhibitors at various concentrations. These inhibitors included
cytochalasin D (CytoD), an actin-depolymerizing drug (Fenteany and
Zhu, 2003), nocodazole, an inhibitor of the polymerization of tubulin
into microtubules (Fenteany and Zhu, 2003), and dimethyl amilorideFig. 1. F-actin and macropinocytosis contribute to DC endocytosis of HIV. DCs (1×105)
were pretreated separately (A) CytoD, (B) nocodazole, and (C) DMA at various
concentrations as indicated, pulsed with HIV-Luc/JRFL (45 ng of p24) in the presence
of DMSO (control in A–C) or the appropriate inhibitors. DCs were then washed,
trypsinized and lysed for HIV Gag p24 quantiﬁcation. Data shown are means±SD (n=3).(DMA), a macropinocytosis-speciﬁc inhibitor that does not affect
receptor-mediated endocytosis (Maréchal et al., 2001; Sallusto et al.,
1995). Dimethyl sulfoxide (DMSO) was used as a solvent control.
HIV-pulsed DCs were trypsinized after extensive washes to strip
cell-surface-boundHIV, and the Gag p24 in DCs lysateswas quantiﬁed.
The treatment with CytoD at a concentration of 0.5 μM decreased DC-
associated p24 in iDCs and mDCs by 33% and 28% (P≤0.004),
respectively (Fig. 1A). In contrast, at higher concentrations (3 and
5 μM), CytoD treatment slightly increased p24 in iDCs by 2–13%, and in
mDCs by 10–30%, suggesting different functions of CytoD at various
concentrations. Nocodazole treatment of DCs did not reduce intracel-
lular HIV p24 (Fig. 1B), indicating that HIV endocytosis in DCs is not
decreased by disruption of microtubules. Interestingly, various
concentrations of DMA treatment diminished HIV endocytosis in
iDCs by 40–48% (P≤0.001), and in mDCs by 32–48% (P≤0.003)
(Fig. 1C). Together, these data imply the involvement of F-actin and
macropinocytosis in DC endocytosis of HIV, suggesting that F-actin-
dependent macropinocytosis is not the only pathway that mediates
HIV endocytosis in DCs. Indeed, other pathways such as clathrin-
mediated HIV endocytosis in DCs have been previously reported
(Frank et al., 2002; Wang et al., 2007b).
DC-mediated HIV transmission is dependent on cytoskeleton
To examine whether disruption of actin cytoskeleton prevents DC-
mediated viral transmission, DCs were pulsed with small amounts of
HIV-Luc/JRFL in the presence of CytoD, then washed and cocultured
with CD4+ Hut/CCR5 T cells for measuring viral transmission. R5-
tropic HIV was used in viral transmission assays given that DC-
mediated infection and transmission of X4-tropic HIV is lower than
that of R5-tropic HIV (Cameron et al., 2007; Granelli-Piperno et al.,
1998; Pion et al., 2007; Smed-Sorensen et al., 2005; Wang et al.,
2007a). Signiﬁcantly, treatment of DCs with CytoD at various
concentrations blocked mDC-mediated HIV transmission to CD4+ T
cells by 67–82% (P≤0.00003), while iDC-mediated viral transmission
decreased by 28–48% (P≤0.02) (Fig. 2A).
To examine the role of microtubules in DC-mediated HIV
transmission, nocodazole was used to disrupt the microtubule
network. Pretreatment of DCs with nocodazole dramatically blocks
iDC- and mDC-mediated HIV transmission by 89–94% (P≤0.000002)
(Fig. 2B). As a negative control, no viral infection was detected in HIV-
pulsed DCs without T cells (Fig. 2B, D,C alone), indicating that the
infectionwas from DC-mediated trans-infection of CD4+ T cells, rather
than cis-infection of DCs. Thus, disrupting cytoskeleton inhibits DC-
mediated HIV transmission.
Interestingly, blocking HIV macropinocytosis with DMA efﬁciently
inhibited mDC-mediated HIV transmission by 46–88% (P≤0.0008),
whereas iDC-mediated viral transmission decreased by 34–70%
(P≤0.004) (Fig. 2C). The DMA inhibitory effect of iDC- and mDC-
mediated HIV transmission was dose-dependent (Fig. 2C), suggesting
that macropinocytosis-mediated HIV entry into DCs plays an
important role in viral transmission, at least in part.
To conﬁrm the results obtained using the allogeneic CD4+ T-cell
line Hut/CCR5, primary CD4+ T cells and peripheral blood lymphocytes
(PBLs) were used as autologous target cells in DC-mediated HIV
transmission assays. Separate treatment of DCs with CytoD and
nocodazole blocked DC-mediated HIV transmission to activated
primary CD4+ T cells by 71–97% (P≤0.0001) (Fig. 2D), while the viral
transmission to activated PBLs was reduced by 45–57% (P≤0.002)
(Fig. 2E). DMA treatment impaired DC-mediated HIV transmission to
primary CD4+ T cells (Fig. 2D) and PBLs (Fig. 2E) by 28–47% (P≤0.05)
and 39–50% (P≤0.01), respectively. Moreover, post-treatment of HIV-
pulsed DCs with CytoD or nocodazole signiﬁcantly impaired DC-
mediated HIV transmission by 4–8-fold (Pb0.001) (Fig. 2F). As a
control, the treatment of DCs with CytoD, nocodazole and DMA for
2.5 h did not affect DC viability after 3 days in culture (Figs. 2G and H).
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quired for DC-mediated HIV transmission to CD4+ T cells.
Disruption of the cytoskeleton in DC-T-cell cocultures inhibits DC-
mediated HIV transmission
To examine whether disruption of the cytoskeleton in DC-T-cell
cocultures blocks HIV transmission to CD4+ T cells, DCs were pulsed
with HIV-Luc/JRFL, washed and cocultured with Hut/CCR5 cells in the
presence of CytoD or nocodazole for 5, 30, 60 and 120 min. Cells were
then washed and cultured for 3 days before measuring HIV infection.
CytoD treatment at the different time efﬁciently reduced DC-mediated
HIV transmission 7–8-fold (P≤0.0001) (Fig. 3A). No viral infectionwas
detected in HIV-pulsed DCs without T-cell coculture (not shown). As a
parallel control, HIV infection of T cells decreased around 2-fold by the
CytoD treatment, which is signiﬁcantly lower than the inhibition of
DC-mediated viral transmission (Pb0.0001) (Fig. 3B). Similar results
and statistical analysis were obtained when replication-competent
HIVNLAD8 was examined (Figs. 3C and D).
Moreover, signiﬁcant inhibition of DC-mediated HIV transmission
was observed when nocodazole was present in DC-T-cell cocultures
(Fig. 3E). In contrast, the transient nocodazole treatment had no
signiﬁcant effect on HIV infection of CD4+ T cells (data not shown),
consistent with a previous report indicating that HIV infection does
not require microtubules (Bukrinskaya et al., 1998). As a control, DMA
treatment in the T-cell coculture with HIV-pulsed DCs for 0.5–2 h did
not affect viral transmission (Fig. 3F), conﬁrming that DMA inhibition
of HIV transmission requires pretreatment of DCs to block macro-
pinocytosis-mediated viral entry. Thus, disruption of cytoskeleton in
DC-T-cell coculture efﬁciently inhibits DC-mediated HIV transmission
to CD4+ T cells.
Cytoskeleton inhibitors alter HIV trafﬁcking in mDCs
To investigate the mechanisms by which disruption of the
cytoskeleton inhibits DC-mediated HIV transmission, viral trafﬁcking
were examined using Vpr-GFP-tagged replication-competent HIV
(HIV-Vpr-GFP) (McDonald et al., 2002). Fewer HIV-Vpr-GFP were
observed on the iDC surface or internalized in iDCs, while a large
number of viral particles were internalized and concentrated in the
cytosol of mDCs (Fig. 4A, left). These results conﬁrm that mDCs sig-
niﬁcantly facilitate HIV endocytosis, consistent with the previous
observations (Fahrbach et al., 2007; Frank et al., 2008; Garcia et al.,
2005; McDonald et al., 2003; Turville et al., 2004; Wang et al., 2007b).
Treatment of DCswith CytoD, but not DMA, resulted in depolarized
F-actin in DCs and altered HIV trafﬁcking (Fig. 4A, middle and right).
The altered HIV trafﬁcking was more profound in mDCs than that in
iDCs, as viruses became diffused and localized more close to the
plasma membrane of mDCs (Fig. 4A, middle). Furthermore, nocoda-
zole treatment altered microtubule organization in DCs (Fig. 4B). The
altered HIV trafﬁcking in mDCs was also observed as HIV particles
became diffusely localized closer to the plasma membrane of mDCs
(Fig. 4B). Quantitative image analysis indicated that DMA treatment
reduced HIV-positive iDCs and mDCs by 14% and 30% (Pb0.05),
respectively, while the treatment with CytoD or nocodazole did not
signiﬁcantly alter the number of HIV-positive DCs (Figs. 4C and D).
These data are consistent with the quantiﬁcation results of DC-
associated HIV p24 (Fig. 1).
HIV targets the CD81-rich compartment in mDCs and spreads to
the DC-T-cell VS via a tetraspanin-sorting pathway (Fahrbach et al.,
2007; Garcia et al., 2005, 2008; Izquierdo-Useros et al., 2007). Notably,
separate treatment with CytoD and nocodazole drastically disrupted
HIV colocalizationwith CD81 in mDCs (Fig. 4E). Correlation analysis of
the colocalization images indicated that the treatment of CytoD and
nocodazole signiﬁcantly impaired the colocalization of HIV with CD81
in mDCs (Pb0.0001) (Fig. 4F). The colocalization of CD81 and HIV inmDCs was signiﬁcantly higher than that in iDCs (Pb0.0001) (Fig. 4F).
Thus, disruption of the cytoskeleton alters HIV trafﬁcking in mDCs,
which likely contributes to the inhibition of viral transmission.
Examination of HIV trafﬁcking in mDCs treated with various inhibitors
by electron microscopy (EM)
To better visualize HIV trafﬁcking within mDCs, transmission EM
was used to examine mDCs pulsed with aldrithiol-2 (AT-2)-inacti-
vated HIV in the presence of the macropinocytosis and cytoskeleton
inhibitors. Previous studies have shown that AT-2-inactivated HIV is
conformationally authentic and interacts with DCs similarly to
infectious viruses (Frank et al., 2002, 2008; Turville et al., 2004;
Wang et al., 2007b). Using ruthenium red labeling of plasma
membranes, our recent EM studies demonstrated that signiﬁcantly
more HIV particles were internalized in the intracellular compart-
ments in mDCs compared with those in iDCs (Wang et al., 2007b).
In addition to some surface-associated HIV, numerous intact HIV
particles were observed in macropinosome-like compartments within
mDCs in the presence of DMSO (Fig. 5A), which is consistent with our
previous observations (Wang et al., 2007b). By contrast, DMA
treatment signiﬁcantly altered HIV trafﬁcking, as fewer HIV particles
were observed in endocytic compartments (Fig. 5B) that were
generally much smaller. CytoD treatment appeared to result in
diffused HIV distribution in numerous endocytic compartments
(Fig. 5C). Nocodazole treated mDCs showed depolymerized micro-
tubules and fewer HIV particles in HIV-containing compartments
relative to the DMSO control (Fig. 5D).
To better compare the effects of the inhibitor on HIV trafﬁcking,
quantitative analysis of EM images was performed. In each sample,
100 cells were imaged and scored for presence of virus within internal
compartments. Additionally, the number of HIV-containing cells that
had compartments with greater than 5 virions per compartment were
counted. Compared with DMSO control, DMA treatment signiﬁcantly
reduced HIV entry into mDCs (Pb0.001) (Fig. 5E, left), and the
inhibitor treatment largely altered HIV distribution in mDCs (Fig. 5E,
right). These EM results suggest that, in mDCs, macropinocytosis of
HIV is a major viral entry pathway, and that cytoskeletal inhibitors can
alter HIV trafﬁcking.
CytoD treatment of DCs transiently impairs the formation of DC-T-cell
clustering
Our recent results indicate that DC-T-cell contact is required for
DC-mediated HIV transmission (Wang et al., 2007b). To examine
whether DC-T-cell clustering is impaired by the treatment of CytoD,
nocodazole, or DMA, DCs were pretreated with these inhibitors, and
pulsed with HIV-Luc/JRFL in the presence of the appropriate in-
hibitors. DCs were then cocultured with Hut/CCR5 cells and examined
for DC-T-cell clustering. The transient treatment of HIV-pulsed DCs
with CytoD, but not nocodazole and DMA, strongly blocked the
formation of DC-T-cell clustering after 1 h in cocultures (Fig. 6). How-
ever, the impaired DC-T-cell clustering of CytoD-treated DCs re-
established after 5–7 h in cocultures (Fig. 6), suggesting that CytoD
treatment is reversible. Nevertheless, the impaired DC-T-cell cluster-
ing by CytoD treatment likely also contributed to the decreased HIV
trans-infection.
Disrupting the cytoskeleton impairs the formation of VS
To examine if the disruption of the cytoskeleton impairs VS
formation, HIV-Vpr-GFP-pulsed DCs were cocultured with CD4+ T cells
in the presence or absence of the cytoskeleton inhibitors, and the VS
were visualized by immunoﬂuorescence microscopy. More HIV
particles were recruited to mDC-T-cell junctions than those to iDC-T-
cell junctions (Figs. 7A and B, upper). Intriguingly, treatment with
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Fig. 3. Disruption of the cytoskeleton in DC-T-cell cocultures inhibits DC-mediated HIV transmission. (A) and (C) CytoD treatment of DC-T-cell cocultures blocks HIV trans-infection of
CD4+ T cells. DCs (3×105) were pulsed separately with HIV-Luc/JRFL (0.2 MOI) (A) or HIV-1NL-AD8 (40 ng of p24) (C), and cocultured with Hut/CCR5 cells in the presence or absence of
CytoD for the indicated time. Cells were thenwashed and cocultured for an additional 3 days. HIV transmissionwas determined by measuring luciferase activity in cell lysates (A) or
HIV p24 in supernatants (C). (B) and (D) Statistical analysis of the CytoD inhibition of DC-mediated HIV trans-infection compared with that of cis-infection of T cells. DC-mediated HIV
transmission (iDC+T and mDC+T) was performed as described in A and C. In parallel, HIV cis-infection of Hut/CCR5 cells (T-cell infection) in the presence of CytoD was detected
3 days post-infection. Data shown are means of each time point from at least 3 independent experiments. Each dot represents one sample result from multiple independent
experiments. (E) Nocodazole, but not (F) DMA in DC-T-cell cocultures blocks DC-mediated HIV transmission. HIV transmission assays were performed as described in (A). cps, counts
per second. Data shown are means±SD (n≥3).
147J.-H. Wang et al. / Virology 381 (2008) 143–154CytoD (Fig. 7A) and nocodazole (Fig. 7B) strongly impaired VS
formation between DCs and T cells. Quantitative image analysis of
the DC-T-cell conjugates revealed that the CytoD and nocodazole
treatment signiﬁcantly impaired VS formation by 36–51% (P≤0.001)
(Figs. 7C and D, comparing the percentages of the “type a” conjugates
in the presence or absence of the inhibitors). In addition, these
observations were conﬁrmed using autologous DCs and PBLs with
speciﬁc staining of the T-cell marker CD3. Similar results were also
obtainedwhen DCswere treated with CytoD and nocodazole before or
after HIV incubation (Wang and Wu, unpublished data). Thus, intactFig. 2. Cytoskeleton and HIV macropinocytosis contribute to DC-mediated HIV transmissio
transmission to Hut/CCR5 cells. (D) Primary CD4+ T cells and (E) PBLs were used as target cel
pulsed with HIV-Luc/JRFL (0.2 MOI) in the presence of DMSO or the appropriate inhibitors. D
detecting the luciferase activity in cell lysates. (F) Post-treatment of HIV-pulsed DCs with C
pulsed with HIV-Luc/JRFL (0.2 MOI), and then treated with the inhibitors, washed, and cocultu
Transient treatment of CytoD, DMA and nocodazole does not affect DC viability. DCs were trea
before the detection of viability. All data shown are means±SD (n≥3).cytoskeleton is essential for forming the VS and enhancing DC-
mediated HIV transmission.
Discussion
Examining the role of the cytoskeleton in DC-mediated HIV
transmission enriches our understanding of viral pathogenesis. The
present study suggests that HIV exploits the cytoskeleton network of
DCs to facilitate viral dissemination to CD4+ T cells through VS. We
showed that disrupting actin or microtubules in DCs with speciﬁcn. (A) CytoD, (B) nocodazole, and (C) DMA treatment of DCs inhibit DC-mediated HIV
ls in the HIV transmission assays. DCs were pretreated with DMSO or various inhibitors,
Cs were washed, and then cocultured with target cells to measure viral transmission by
ytoD and nocodazole blocks DC-mediated HIV transmission to CD4+ T cells. DCs were
red with Hut/CCR5 cells in viral transmission assays. cps, counts per second. (G) and (H)
ted separately with DMSO or inhibitors at 37°C for 2.5 h, washed and cultured for 3 days
Fig. 4. Cytoskeleton inhibitors alter HIV trafﬁcking inmDCs. (A) CytoD treatment alters HIV trafﬁcking inmDCs. DCs were pretreatedwith DMSO, CytoD, or DMA and pulsed with HIV-
Vpr-GFP (green) (40 ng of p24) in the presence of the appropriate inhibitors. DCs were ﬁxed and then stained for F-actin (red, phalloidin) and nucleus (blue, DAPI). (B) Nocodazole
treatment alters HIV trafﬁcking in mDCs. DCs were pulsed with HIV-Vpr-GFP (green) (40 ng of p24) in the presence of DMSO or nocodazole. DCs were ﬁxed and stained for α-tubulin
(red) and analyzed by confocal microscopy. Quantitative image analysis of HIV-positive DCs in the presence or absence of (C) CytoD, DMA, and (D) nocodazole. DCs were counted
based on the experiments described in A and B. (E) Localization of CD81 and HIV in DCs treated with CytoD or nocodazole. DCs were pulsed separately with HIV-Vpr-GFP (green)
(40 ng of p24) in the presence of DMSO or the inhibitors and stained for CD81 (red). (F) Pearson's correlation analysis of HIV colocalization with CD81 in DCs. The analysis was based
on the experiment described in E. The dots represent the r2 values of Pearson coefﬁcient derived from individual DC images. Noc, nocodazole. Scale bars, 5 μm (A and E), and 3 μm (B).
148 J.-H. Wang et al. / Virology 381 (2008) 143–154inhibitors signiﬁcantly inhibited DC-mediated HIV transmission. The
inhibition of HIV transmission was mainly due to altered viral
trafﬁcking and impaired formation of VS. Our results deﬁne a new
mechanism underlying DC-mediated HIV transmission to T cells
through the cytoskeleton network.
In our experiments, transient treatment of cells with the cyto-
skeleton inhibitors appeared to disrupt the cytoskeleton network,rather than directly affecting HIV infectivity. It has been shown that
the pretreatment of peripheral blood mononuclear cells, but not
HIV, with CytoD, inhibited viral entry and infection (Iyengar et al.,
1998). In addition, Campbell et al. observed amodest increase of HIV
infection when treating HeLa cell-derived HIV indicator cells with
CytoD and performing viral infection in the presence of CytoD
(Campbell et al., 2004). Although no signiﬁcant cytotoxicity was
Fig. 5. Examination of HIV trafﬁcking in mDCs treated with various inhibitors by EM. mDCs (6×105) were incubated with AT-2-inactivated HIV (2 μg of p24) at 37 °C for 2 h in the
presence of (A) DMSO, (B) DMA (C) CytoD, and (D) nocodazole, DCs were then washed, ﬁxed and processed for thin sections of conventional transmission electron microscopy. The
black arrowheads point to HIV particles. Scale bars, 0.5 μm (A, B, and D), 1 μm (C). (E) Quantitative analysis of EM results. The numbers of mDCs with HIV compartments in 100 cells
from each sample (left), and the numbers of cells that had compartments with greater than 5 virions per compartment (right) were labeled.
149J.-H. Wang et al. / Virology 381 (2008) 143–154detected with the transient treatment of the cytoskeleton inhibi-
tors, these inhibitors may have broad or pleiotropic effects on
intracellular trafﬁcking and mechanical properties of cells. For
example, the drug treatment may nonspeciﬁcally alter trafﬁcking
or function of some cellular proteins that are required for VS
formation. Thus, further studies might provide the mechanism
details underlying the role of cytoskeleton in DC-mediated HIV
trans-infection.
Recent studies also suggest an important role of cytoskeleton in
DC-mediated HIV transmission. Leukocyte-speciﬁc protein 1 (LSP1),an F-actin binding protein involved in leukocyte motility, binds to DC-
SIGN (for “DC-speciﬁc intercellular adhesion molecule 3 [ICAM-3]-
grabbing nonintegrin”) and directs internalized HIV to the proteasome
in DCs for viral degradation (Smith et al., 2007). Silencing LSP1
expression in DCs promotes HIV transmission to CD4+ T cells,
suggesting that HIV trafﬁcking through the cytoskeleton is important
for viral transmission (Smith et al., 2007). Moreover, HIV or DC-SIGN-
speciﬁc antibodies can activate DC-SIGN signaling through the
leukemia-associated Rho guanine nucleotide-exchange factor
(LARG), which increases Rho-GTPase activity (Hodges et al., 2007).
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Fig. 6. CytoD treatment of DCs transiently impairs the formation of DC-T-cell clustering. DCs were pretreated with DMSO, CytoD, nocodazole, or DMA, and pulsed with HIV-Luc/JRFL
(0.2 MOI) in the presence of DMSO or the appropriate inhibitors. DCs were then cocultured with Hut/CCR5 cells for indicated time and examined by a light microscope. DC-T-cell
clustering appears as dark aggregates of cells. Original magniﬁcations, 40×.
Fig. 7.Disruption of the cytoskeleton impairs the formation of VS. (A) Actin disruption impairs VS formation between DCs and CD4+ T cells. DCs were pulsed with HIV-Vpr-GFP (green)
(40 ng of p24), washed and cocultured with Hut/CCR5 cells in the presence of DMSO or CytoD. Cells were then ﬁxed, stained for F-actin (red, phalloidin) and HA-tagged CCR5 (blue/
purple) of Hut/CCR5 cells. (B) Nocodazole treatment of DCs impairs VS formation. DCs were pretreated with DMSO or nocodazole, and then pulsed separately with HIV-Vpr-GFP
(green) (40 ng of p24) in the presence of DMSO or nocodazole. After washes, DCs were cocultured with Hut/CCR5 cells, ﬁxed and stained for α-tubulin (blue) and HA-CCR5 (red) of
Hut/CCR5 cells. Scale bars, 5 μm (A and B). (C) and (D) Quantitative image analysis of the DC-T-cell conjugates and the VS. DC-T-cell conjugates in C and D were counted and analyzed
according to the experiments described in (A) and (B), respectively.
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152 J.-H. Wang et al. / Virology 381 (2008) 143–154Activation of LARG in DCs facilitates HIV trans-infection of CD4+ T cells,
likely by enhancing VS formation between DCs and T cells (Hodges
et al., 2007).
Notably, different concentrations of CytoD treatment had distinct
effects on DC uptake of HIV (Fig. 1A), which might result from
the distinct inhibitory functions of CytoD at different concentrations.
CytoD reversibly binds the barbed end of F-actin at low concentrations
and prevents F-actin recycling. At higher concentrations, CytoD binds
2 actin monomers (G-actin) and promotes the hydrolysis of bound
ATP, creating low afﬁnity ADP-G actin forms (Fenteany and Zhu, 2003).
In fact, CytoD treatment has concentration-dependent effects on the
mechanical properties of the cells (Wakatsuki et al., 2001), which
might inﬂuence HIV binding to DCs and viral trafﬁcking in DCs.
Moreover, higher concentrations of CytoD treatment of DCs might
reduce or delay intracellular degradation of internalized HIV, resulting
in intracellular retention of HIV and increased p24 detection.
We demonstrated that macropinocytosis partially contributed to
HIV endocytosis in DCs, thereby affecting DC-mediated HIV transmis-
sion to CD4+ T cells. Gummuluru et al. have reported the existence of
C-type lectin receptor-independent and heparan sulfate proteoglycan-
independent mechanisms of DC-mediated HIV internalization and
transmission (Gummuluru et al., 2003). We recently reported that
mDCs are more efﬁcient than iDCs to transfer HIV to various types of
target cells independently of C-type lectins (Wang et al., 2007b).
Previous studies indicated that mDCs signiﬁcantly facilitate HIV
endocytosis and efﬁciently concentrate HIV at the VS, which
contributes to mDC-enhanced viral transmission, at least in part
(Turville et al., 2004; Wang et al., 2007b). We have conﬁrmed that HIV
did not strongly colocalize with the markers of endolysosomal
trafﬁcking in DCs, such as transferrin and LysoTracker (Wang and
Wu, unpublished results). These results are in accordance with pre-
vious observations (Fahrbach et al., 2007; Garcia et al., 2005, 2008;
Izquierdo-Useros et al., 2007; Trumpfheller et al., 2003; Turville et al.,
2004), suggesting that HIV trafﬁcking in DCs is not through the
conventional endolysosomal pathway. Based on these published
results and our present data, we propose that macropinocytosis-
mediated HIV endocytosis in DCs, particularly in LPS-induced mDCs,
may result in the formation and trafﬁcking of macropinosomes that
conﬁne concentrated viral particles. Upon DC-T-cell contact, macro-
pinosome-conﬁned HIV in DCs might recycle to the cell surfaces and
transfer to cocultured CD4+ Tcells. Further studies of DC-mediated HIV
transmission process using live cell images are carried out to examine
this hypothesis.
Using dextran as a marker of endocytosis in DCs, previous studies
reported that macropinocytosis in mDCs is signiﬁcantly decreased
relative to that in iDCs (Frank et al., 2002; Izquierdo-Useros et al.,
2007; Sallusto et al., 1995). Indeed, we conﬁrmed that uptake of
ﬂuorescein isothiocyanate-labeled dextran in iDCs was higher than
that in mDCs (Wang and Wu, unpublished results). The differing
efﬁciencies of HIV and dextran endocytosis in iDCs and mDCs might
result from their distinct interactions. It has been shown that
macropinocytosis and multilectin receptor-mediated endocytosis
contribute to the uptake of dextran by DCs (Kato et al., 2000; Sallusto
et al., 1995). DC maturation downregulates the cell-surface expression
levels of some C-type lectin receptors, including mannose receptor
and DC-SIGN (DC-speciﬁc intercellular adhesion molecule-3 grabbing
nonintegrin) (Sallusto et al., 1995; Wang et al., 2007b). The down-
regulated receptors inmDCsmight contribute to the decreased uptake
of dextran relative to iDCs. Thus, it is important to note that dextran
cannot be a marker for HIV endocytosis in DCs.
Our previous study (Wang et al., 2007b) and the present results
suggest that both cell-surface-bound and internalized HIV contribute
to DC-mediated viral transmission. Compared with iDC-mediated HIV
transmission, viral trafﬁcking in mDCs appears to play a more
important role in trans-infection (Fahrbach et al., 2007; Garcia et al.,
2005; Izquierdo-Useros et al., 2007; Turville et al., 2004; Wang et al.,2007b). By contrast, Cavrois et al. suggested that DC-mediated HIV
trans-infection mainly derives from DC surface-bound virions (Cavrois
et al., 2007, 2008). Despite different approaches used in these studies,
the dynamic trafﬁcking and recycling of internalized HIV to DC
surfaces could also mediate viral transmission, which should be an
important consideration in DC-mediated HIV trans-infection. In
addition, Cavrois et al. proposed that trypsin might be less potent
than pronase at removing DC surface-bound HIV, but failed to present
any results (Cavrois et al., 2007). By contrast, our comparison study
indicated that pronase treatment (250 μg/ml) reduced iDC- and mDC-
mediated HIV transmission by 48% and 24%, respectively (Wang et al.,
2007b). These data were comparable to those of trypsin treatment at
the same concentration (Wang et al., 2007b), suggesting that both
trypsin and pronase may strip surface HIV from DCs with similar
efﬁciencies. However, the proteolysis treatment may not completely
remove DC surface-bound HIV due to the complex cell-surface
invaginations of DCs (Wang et al., 2007b).
Reversible or topical disruption of the cytoskeleton might be
considered as a potential approach in the prevention and therapy of
HIV infection. Indeed, there are many small molecules that either
directly target the actin cytoskeleton, or inhibit actin-binding proteins
and other immediate regulators of actin dynamics (Fenteany and Zhu,
2003). It would be interesting to explore whether some of these
cytoskeleton inhibitors can be developed as antiviral agents against
HIV transmission in vivo.
The actin cytoskeleton contributes to T-cell activation by forming
immunological synapses between antigen-presenting cells and T cells
(Dustin and Cooper, 2000). Interestingly, the immunological synapses
appear to share structural similarities with the VS andmay play a role in
HIV pathogenesis (Fackler et al., 2007; Piguet and Sattentau, 2004).
While HIV facilitates cell-to-cell transmission by promoting VS
formation, HIV infection impairs the formation of the immunological
synapses (Thoulouze et al., 2006). HIV infection of DCs and T cells may
result in a balance between the formation of the VS and the impairment
of the immunological synapses, thereby enhancing cell-mediated HIV
dissemination and impairing antiviral immune responses. Therefore,
the inﬂuence of the structure and function of immunological synapses
should be also considered in the development of potential anti-HIV
interventions by targeting the cytoskeleton.
Materials and methods
Cell culture
PBLs, CD4+ T cells and CD14+ monocytes were isolated from buffy
coat units of healthy blood donors as previously described (Wang
et al., 2007a). Monocyte-derived iDCs and LPS-induced mDCs were
generated from puriﬁed CD14+ monocytes as previously described
(Wang et al., 2007b). PBLs and primary CD4+ T cells were cultured in
the presence of recombinant interleukin-2 (the NIH AIDS Research
and Reference Reagent Program) and activated by phytohemaggluti-
nin as described (Wang et al., 2007a). DCs and CD4+ T cells were more
than 98.5% pure by ﬂow cytometry analysis of surface markers as
previously described (Dong et al., 2007; Wang et al., 2007b; Wu et al.,
2002). HEK293T, Hut/CCR5, and GHOST/R5 cell lines have been
previously described (Wang et al., 2007a).
HIV stocks
HIV-Luc/JRFL stocks were generated by cotransfections of HEK293T
cells with the pLai3ΔenvLuc2 and an expression plasmid for HIV-1JRFL
Env as previously described (Wang et al., 2007a). HIV-1NL-AD8 stocks
were generated by transfections of HEK293T cells with the proviral
construct pNLAD8 as previously described (Dong et al., 2007; Janas
et al., 2008). The infectivity of the virus stocks was evaluated by
limiting dilution on GHOST/R5 cells as previously described (Wang
153J.-H. Wang et al. / Virology 381 (2008) 143–154et al., 2007b). HIV-Vpr-GFP stocks were generated by cotransfections
of HEK293Tcells with pNLAD8 and a Vpr-GFP expression vector pGFP-
Vpr (a gift from David McDonald, Case Western Reserve University) as
previously described (McDonald et al., 2002). AT-2-inactivated R5-
tropic HIV-1 (ADA/Supt1-CCR5 cl30) was a kind gift from Jeffery Lifson
(AIDS Vaccine Program, SAIC, Frederick, MD).
HIV internalization, infection and transmission assays
For HIV internalization, DCs (1×105) were incubated separately with
HIV-Luc/JRFL (45 ng of p24) at 37 °C for 2 h. DCs were washed
intensively, trypsinized and washed before lysis for HIV p24 quantiﬁca-
tion by ELISA as previously described (Wang et al., 2007b). HIV infection
and transmission assays were performed as previously described (Dong
et al., 2007; Wang et al., 2007a). For inhibitor treatment, DCs were
preincubated separately with CytoD, DMA, or nocodazole (all inhibitors
were purchased from Sigma-Aldrich) at the indicated concentrations at
37 °C for 0.5 h, and then pulsed with infectious HIV (0.2 multiplicity of
infection, MOI) at 37 °C for 2 h in the presence of the appropriate
inhibitors. For post-treatment of HIV-pulsed DCs with CytoD and
nocodazole in HIV transmission assays, DCs were pulsed with HIV-Luc/
JRFL (0.2 MOI), and then treated with the inhibitors for 30 min before
wash and coculturing with CD4+ T cells. If not indicated in ﬁgures, the
inhibitor concentrations used in HIV transmission assays were: CytoD
(3 μM), nocodazole (20 μM), and DMA (100 μM). HIV-pulsed DCs were
lysed for p24 detection or coculturing with the indicated target cells for
viral transmission assays.
Examination of DC viability
DCs were treated separately with DMSO (control, 0.25%), CytoD
(5 μM), DMA (100 μM), and nocodazole (20 and 35 μM) at 37°C for
2.5 h, washed and cultured for 3 days. DC viability was then
determined by trypan blue (Invitrogen) exclusion according to the
product instruction.
Examination of DC and T-cell clustering
DCs were pretreated separately with DMSO (0.25%), CytoD (3 μM),
nocodazole (20 μM) and DMA (100 μM) at 37 °C for 30 min, pulsed
with HIV-Luc/JRFL at 37 °C for 2 h in the presence of DMSO or the
appropriate inhibitors. DCs were washed, cocultured with Hut/CCR5
cells at 37 °C for indicated time, and then examined by the bright ﬁeld
of a microscope (Nikon Eclipse TE2000U).
Immunoﬂuorescence, confocal microscopy and virological synapse assay
DCs were pretreated with DMSO (0.25%), CytoD (3 μM), or
nocodazole (20 μM) at 37 °C for 0.5 h, pulsed with HIV-Vpr-GFP in
the presence or absence of the inhibitors at 37 °C for 1.5 h. DCs were
then washed, ﬁxed and permeabilized. DCs were stained with DAPI,
labeled with Alexa Fluor 546-conjugated phalloidin (Invitrogen), or
stained separately with anti-α-tubulin (clone TU-01, Invitrogen) and
anti-CD81 (clone JS-81, BD Biosciences), and then followed by Alexa
Fluor 568-labeled secondary IgG (Invitrogen) as described (Wang
et al., 2007a).
Virological synapse assays were performed as previously described
(Garcia et al., 2005) with slight modiﬁcations. For the CytoD treatment
in the cocultures, DCs (1×105) were pulsed with HIV-Vpr-GFP (40 ng
of p24) at 37 °C for 2 h. After washes, HIV-pulsed DCs were cocultured
with Hut/CCR5 cells (1×105) for 0.5 h in presence of CytoD (3 μM) or
DMSO (0.25%). Cells were then adhered on a poly-L-lysine-coated
microscope slide at 37 °C for 0.5 h, ﬁxedwith 4% paraformaldehyde for
1 h, and permeabilizedwith 0.1% Triton X-100 in PBS for 2min at room
temperature as described (Wang et al., 2007a). Cells were labeled with
Alexa Fluor 546-conjugated phalloidin, and then stained for hemag-glutinin (HA)-tagged CCR5 on Hut/CCR5 cells with anti-HA (Roche),
and followed by Alexa Fluor 633-labeled secondary IgG (Invitrogen).
For the nocodazole treatment in the cocultures, DCs (1×105) were
pretreated with nocodazole (20 μM) at 37 °C for 0.5 h, and then
incubated with HIV-Vpr-GFP (40 ng of p24) in the presence of
nocodazole for 2 h. After washes, DCs were cocultured with Hut/CCR5
cells for 1 h, ﬁxed and permeabilized as described above. Cells were
ﬁrst stained with anti-α-tubulin labeled with Alexa Fluor 647 using a
Zenon One labeling kit (Invitrogen). Cells were washed, ﬁxed, and
then stained with anti-HA that has been labeled with Alexa Fluor 568
using a Zenon One labeling kit (Invitrogen). Stained cells were
examined using a laser scanning confocal microscope (Leica TCS
SP2) or a ﬂuorescence microscope (Nikon Eclipse TE2000U) and
analyzed with MetaMorph software (Version 7.0r4) as described
(Wang et al., 2007a). Pearson correlation analysis for the quantiﬁca-
tion of colocalization was performed using ImageJ software with the
JACoP plugin (Bolte and Cordelieres, 2006).
Electron microscopy
mDCs (6×105) were incubated with AT-2-inactivated HIVADA
(2 μg of p24) at 37 °C for 2 h in presence of DMA (100 μM), CytoD
(3 μM), nocodazole (20 μM), or DMSO (0.25%). After a complete wash,
DCs were ﬁxed and processed for transmission electron microscopy
as previously described (Wang et al., 2007a,b). Thin sections were
examined with a transmission electron microscope (JEOL 2100
LaB6).
Statistical analyses
Statistical analyses were performed using the ANOVA test,
Wilcoxon's paired, or Mann–Whitney's unpaired t-test with Prism
software.
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